24 HR hydromorphone hydrochloride 8 MG Extended Release Oral Tablet — RxCUI 902741
RxNorm drug concept · Semantic clinical drug
RxCUI 902741
Semantic clinical drug · SCD
● Current RxNorm concept 16 FDA products
16 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI902741
Official name24 HR hydromorphone hydrochloride 8 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asHYDROmorphone HCl 8 MG 24HR Extended Release Oral Tablet
FDA products mapped16
Package NDCs mapped16
Reported Medicaid activity (SDUD)606 prescriptions · 11 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Hydromorphone Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Hydromorphone injection is used to treat severe pain when other pain medicines haven't worked well enough. It's an opioid — a strong prescription pain reliever — and it's typically...
- What is hydromorphone injection used for?
- Common side effects include dizziness, drowsiness, nausea, vomiting, itching, sweating, dry mouth, and constipation — these are typical with opioids. But if your breathing feels ve...
- What side effects should I expect, and which ones mean I need to call for help right away?
🕸️ Concept Web — How 24 HR hydromorphone hydrochloride 8 MG Extended... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR hydromorphone hydrochloride 8 MG Extended Release Oral Tablet
RxCUI 902741 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Hydromorphone
3423IN -
Hydromorphone hydrochloride
203177PIN
-
Hydromorphone
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Hydromorphone Extended Release Oral Tablet
902728SCDF -
Hydromorphone hydrochloride Extended Release Oral Tablet
2649153SCDFP -
Hydromorphone Oral Product
1164620SCDG -
Hydromorphone Pill
1164621SCDG -
Hydromorphone hydrochloride Oral Product
2659874SCDGP -
Hydromorphone hydrochloride Pill
2661455SCDGP -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Hydromorphone Extended Release Oral Tablet
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Hydromorphone hydrochloride 8 MG
897709SCDC
-
Hydromorphone hydrochloride 8 MG
Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Hydromorphone hydrochloride 8 MG
SCDC · 897709 -
Hydromorphone Extended Release Oral Tablet
SCDF · 902728 -
Hydromorphone hydrochloride Extended Release Oral Tablet
SCDFP · 2649153 -
Hydromorphone Oral Product
SCDG · 1164620 -
Hydromorphone Pill
SCDG · 1164621 -
Hydromorphone hydrochloride Oral Product
SCDGP · 2659874 -
Hydromorphone hydrochloride Pill
SCDGP · 2661455
📦 FDA Products & Package NDCs
16 products · 16 package NDCs
16 package NDCs map to RxCUI 902741 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00574-0293-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0293-01) | hydromorphone hydrochloride | Padagis US LLC | 2015-05-22 |
| 00574-0294-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0294-01) | hydromorphone hydrochloride | Padagis US LLC | 2015-05-22 |
| 00574-0295-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0295-01) | hydromorphone hydrochloride | Padagis US LLC | 2015-05-22 |
| 00574-0297-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0297-01) | hydromorphone hydrochloride | Padagis US LLC | 2017-09-29 |
| 13811-0701-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-701-10) | Hydromorphone Hydrochloride | Trigen Laboratories, LLC | 2016-09-15 |
| 13811-0702-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-702-10) | Hydromorphone Hydrochloride | Trigen Laboratories, LLC | 2016-09-15 |
| 13811-0703-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-703-10) | Hydromorphone Hydrochloride | Trigen Laboratories, LLC | 2016-09-15 |
| 13811-0704-10 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-704-10) | Hydromorphone Hydrochloride | Trigen Laboratories, LLC | 2016-09-15 |
| 31722-0119-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-119-01) | hydromorphone hydrochloride | Camber Pharmaceuticals, Inc. | 2020-09-24 |
| 31722-0120-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-120-01) | hydromorphone hydrochloride | Camber Pharmaceuticals, Inc. | 2020-09-24 |
| 31722-0121-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-121-01) | hydromorphone hydrochloride | Camber Pharmaceuticals, Inc. | 2020-09-24 |
| 31722-0122-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-122-01) | hydromorphone hydrochloride | Camber Pharmaceuticals, Inc. | 2020-09-24 |
| 72865-0168-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-168-01) | hydromorphone hydrochloride | XLCare Pharmaceuticals, Inc. | 2020-09-24 |
| 72865-0169-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-169-01) | hydromorphone hydrochloride | XLCare Pharmaceuticals, Inc. | 2020-09-24 |
| 72865-0170-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-170-01) | hydromorphone hydrochloride | XLCare Pharmaceuticals, Inc. | 2020-09-24 |
| 72865-0171-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (72865-171-01) | hydromorphone hydrochloride | XLCare Pharmaceuticals, Inc. | 2020-09-24 |
Observed labelers:
Camber Pharmaceuticals, Inc. (4) ·
Padagis US LLC (4) ·
Trigen Laboratories, LLC (4) ·
XLCare Pharmaceuticals, Inc. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.